57 related articles for article (PubMed ID: 1581913)
1. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
Borg A; Zhang QX; Alm P; Olsson H; Sellberg G
Cancer Res; 1992 May; 52(10):2991-4. PubMed ID: 1581913
[TBL] [Abstract][Full Text] [Related]
2. Senescence and Apoptosis: Architects of Mammalian Development.
Wanner E; Thoppil H; Riabowol K
Front Cell Dev Biol; 2020; 8():620089. PubMed ID: 33537310
[TBL] [Abstract][Full Text] [Related]
3. SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability.
Liao X; Hong Y; Mao Y; Chen N; Wang Q; Wang Z; Zhang L; Wang L; Shi C; Shi W; Ge H; Li A; Li X; Xia G; Liu Y
Cancer Sci; 2020 May; 111(5):1761-1773. PubMed ID: 32103527
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict's value.
Chow LWC; Morita S; Chow CYC; Ng WK; Toi M
Endocr Relat Cancer; 2018 Feb; 25(2):123-130. PubMed ID: 29158285
[TBL] [Abstract][Full Text] [Related]
5. RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.
Xiong G; Xu R
Mol Cell Biol; 2014 Aug; 34(16):3066-75. PubMed ID: 24891616
[TBL] [Abstract][Full Text] [Related]
6. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.
Francis SM; Chakrabarti S; Dick FA
PLoS One; 2011 Feb; 6(2):e16434. PubMed ID: 21364977
[TBL] [Abstract][Full Text] [Related]
7. RB in breast cancer: differential effects in estrogen receptor-positive and estrogen receptor-negative disease.
Musgrove EA; Sutherland RL
Cell Cycle; 2010 Dec; 9(23):4607. PubMed ID: 21260944
[No Abstract] [Full Text] [Related]
8. Alterations of the retinoblastoma gene in metastatic breast cancer.
Berge EO; Knappskog S; Lillehaug JR; Lønning PE
Clin Exp Metastasis; 2011 Mar; 28(3):319-26. PubMed ID: 21253829
[TBL] [Abstract][Full Text] [Related]
9. RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients.
Chano T; Ikebuchi K; Tomita Y; Jin Y; Inaji H; Ishitobi M; Teramoto K; Ochi Y; Tameno H; Nishimura I; Minami K; Inoue H; Isono T; Saitoh M; Shimada T; Hisa Y; Okabe H
PLoS One; 2010 Dec; 5(12):e15737. PubMed ID: 21203526
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers.
Berge EO; Knappskog S; Geisler S; Staalesen V; Pacal M; Børresen-Dale AL; Puntervoll P; Lillehaug JR; Lønning PE
Mol Cancer; 2010 Jul; 9():173. PubMed ID: 20594292
[TBL] [Abstract][Full Text] [Related]
11. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas.
Herschkowitz JI; He X; Fan C; Perou CM
Breast Cancer Res; 2008; 10(5):R75. PubMed ID: 18782450
[TBL] [Abstract][Full Text] [Related]
12. Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors.
Mathivanan J; Rohini K; Gope ML; Anandh B; Gope R
Mol Cell Biochem; 2007 Aug; 302(1-2):67-77. PubMed ID: 17318405
[TBL] [Abstract][Full Text] [Related]
13. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.
Bosco EE; Wang Y; Xu H; Zilfou JT; Knudsen KE; Aronow BJ; Lowe SW; Knudsen ES
J Clin Invest; 2007 Jan; 117(1):218-28. PubMed ID: 17160137
[TBL] [Abstract][Full Text] [Related]
14. Biological indices in the assessment of breast cancer.
Leong AS; Lee AK
Clin Mol Pathol; 1995 Oct; 48(5):M221-38. PubMed ID: 16696013
[No Abstract] [Full Text] [Related]
15. Surprising dependency for retinoblastoma protein in ras-mediated tumorigenesis.
DeGregori J
Mol Cell Biol; 2006 Feb; 26(4):1165-9. PubMed ID: 16449632
[No Abstract] [Full Text] [Related]
16. Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas.
Thomas R; Prabhu PD; Mathivanan J; Rohini ; Sivakumar D; Jayakumar PN; Devi BI; Satish S; Sastry KV; Gope R
Mol Cell Biochem; 2005 Mar; 271(1-2):113-21. PubMed ID: 15881662
[TBL] [Abstract][Full Text] [Related]
17. CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Arjona D; Lomas J; de Campos JM; Isla A; Rey JA
Br J Cancer; 2003 Jan; 88(1):109-14. PubMed ID: 12556968
[TBL] [Abstract][Full Text] [Related]
18. Rb localization and phosphorylation kinetics correlate with the cellular phenotype of cultured breast adenocarcinoma cells.
Botos J; Barhoumi R; Burghardt R; Kochevar DT
In Vitro Cell Dev Biol Anim; 2002 Apr; 38(4):235-41. PubMed ID: 12197776
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of breast cancer progression.
Dairkee SH; Smith HS
J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):139-51. PubMed ID: 10887488
[TBL] [Abstract][Full Text] [Related]
20. Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.
Gentile M; Olsen K; Dufmats M; Wingren S
Br J Cancer; 1999 May; 80(5-6):843-9. PubMed ID: 10360664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
